Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Effect of Montelukast on Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients.

NCT05959889 is registered in ClinicalTrials.gov with Damanhour University as lead sponsor.

NCT NCT05959889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05959889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Effect of Montelukast on Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients.
Lead sponsor
Damanhour University
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2023
Completion date
December 1, 2024
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, doxorubicin induced cardiotoxicity